Literature DB >> 26482305

Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage.

Ana B Sanchez1, Giuseppe P Varano1, Cyrus M de Rozieres1, Ricky Maung1, Irene C Catalan1, Cari C Dowling1, Natalia E Sejbuk1, Melanie M Hoefer1, Marcus Kaul2.   

Abstract

HIV-1 infection frequently causes HIV-associated neurocognitive disorders (HAND) despite combination antiretroviral therapy (cART). Evidence is accumulating that components of cART can themselves be neurotoxic upon long-term exposure. In addition, abuse of psychostimulants, such as methamphetamine, seems to aggravate HAND and compromise antiretroviral therapy. However, the combined effect of virus and recreational and therapeutic drugs on the brain is poorly understood. Therefore, we exposed mixed neuronal-glial cerebrocortical cells to antiretrovirals (ARVs) (zidovudine [AZT], nevirapine [NVP], saquinavir [SQV], and 118-D-24) of four different pharmacological categories and to methamphetamine and, in some experiments, the HIV-1 gp120 protein for 24 h and 7 days. Subsequently, we assessed neuronal injury by fluorescence microscopy, using specific markers for neuronal dendrites and presynaptic terminals. We also analyzed the disturbance of neuronal ATP levels and assessed the involvement of autophagy by using immunofluorescence and Western blotting. ARVs caused alterations of neurites and presynaptic terminals primarily during the 7-day incubation and depending on the specific compounds and their combinations with and without methamphetamine. Similarly, the loss of neuronal ATP was context specific for each of the drugs or combinations thereof, with and without methamphetamine or viral gp120. Loss of ATP was associated with activation of AMP-activated protein kinase (AMPK) and autophagy, which, however, failed to restore normal levels of neuronal ATP. In contrast, boosting autophagy with rapamycin prevented the long-term drop of ATP during exposure to cART in combination with methamphetamine or gp120. Our findings indicate that the overall positive effect of cART on HIV infection is accompanied by detectable neurotoxicity, which in turn may be aggravated by methamphetamine.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26482305      PMCID: PMC4704202          DOI: 10.1128/AAC.01632-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  87 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity.

Authors:  Kathryn E Medders; Natalia E Sejbuk; Ricky Maung; Maya K Desai; Marcus Kaul
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

Review 3.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

4.  Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death.

Authors:  Arthi Kanthasamy; V Anantharam; Syed F Ali; A G Kanthasamy
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

5.  Peripheral neuropathy in HIV: prevalence and risk factors.

Authors:  Scott R Evans; Ronald J Ellis; Huichao Chen; Tzu-min Yeh; Anthony J Lee; Giovanni Schifitto; Kunling Wu; Ronald J Bosch; Justin C McArthur; David M Simpson; David B Clifford
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

6.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Authors:  Hélène C F Côté; Zabrina L Brumme; Kevin J P Craib; Christopher S Alexander; Brian Wynhoven; Lillian Ting; Hubert Wong; Marianne Harris; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

7.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

8.  Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity.

Authors:  Yunyi Kang; Stefano Tiziani; Goonho Park; Marcus Kaul; Giovanni Paternostro
Journal:  Nat Commun       Date:  2014-04-17       Impact factor: 14.919

9.  FK506 is neuroprotective in a model of antiretroviral toxic neuropathy.

Authors:  Sanjay C Keswani; Bani Chander; Chiler Hasan; John W Griffin; Justin C McArthur; Ahmet Hoke
Journal:  Ann Neurol       Date:  2003-01       Impact factor: 10.422

10.  Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons.

Authors:  Yulin Zhang; Fengli Song; Ziyun Gao; Wei Ding; Luxin Qiao; Sufang Yang; Xi Chen; Ronghua Jin; Dexi Chen
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more
  30 in total

Review 1.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

Review 2.  Autophagy in acute brain injury.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Klas Blomgren; Guido Kroemer
Journal:  Nat Rev Neurosci       Date:  2016-06-03       Impact factor: 34.870

Review 3.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

Review 4.  Human Immunodeficiency Virus Promotes Mitochondrial Toxicity.

Authors:  Summer J Rozzi; Valeria Avdoshina; Jerel A Fields; Margarita Trejo; Hoai T Ton; Gerard P Ahern; Italo Mocchetti
Journal:  Neurotox Res       Date:  2017-07-10       Impact factor: 3.911

5.  Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.

Authors:  Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

6.  Association of antiretroviral therapy with brain aging changes among HIV-infected adults.

Authors:  Virawudh Soontornniyomkij; Anya Umlauf; Benchawanna Soontornniyomkij; Ben Gouaux; Ronald J Ellis; Andrew J Levine; David J Moore; Scott L Letendre
Journal:  AIDS       Date:  2018-09-10       Impact factor: 4.177

Review 7.  Role of Autophagy in HIV Pathogenesis and Drug Abuse.

Authors:  Lu Cao; Alexey Glazyrin; Santosh Kumar; Anil Kumar
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 8.  Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.

Authors:  Ankit Shah; Mohitkumar R Gangwani; Nitish S Chaudhari; Alexy Glazyrin; Hari K Bhat; Anil Kumar
Journal:  Neurotox Res       Date:  2016-06-30       Impact factor: 3.911

9.  Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.

Authors:  Kelly L Stauch; Katy Emanuel; Benjamin G Lamberty; Brenda Morsey; Howard S Fox
Journal:  J Neurovirol       Date:  2017-09-11       Impact factor: 2.643

Review 10.  Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy.

Authors:  Ming-Lei Guo; Shilpa Buch
Journal:  Brain Res       Date:  2019-09-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.